Udi Dayan Yehuda - 18 Mar 2026 Form 3 Insider Report for NICE Ltd. (NICE)

Role
VP, Corporate Finance
Signature
/s/ Alon Levy, Attorney-in-Fact for Udi Dayan Yehuda
Issuer symbol
NICE
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 09:22:02 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dayan Udi Yehuda VP, Corporate Finance 221 RIVER STREET, HOBOKEN /s/ Alon Levy, Attorney-in-Fact for Udi Dayan Yehuda 18 Mar 2026 0002096666

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NICE Options 18 Mar 2026 Ordinary Shares 750 $0.3060 Direct F1
holding NICE Options 18 Mar 2026 Ordinary Shares 325 $0.2833 Direct F2
holding NICE Options 18 Mar 2026 Ordinary Shares 825 $0.2531 Direct F3
holding NICE Options 18 Mar 2026 Ordinary Shares 1,100 $0.2687 Direct F4
holding NICE Options 18 Mar 2026 Ordinary Shares 3,000 $0.3134 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and currently exercisable.
F2 The stock option is vested and exercisable with respect to 162 Ordinary Shares and will vest with respect to the remaining shares on November 1, 2026.
F3 The stock option is vested and exercisable with respect to 275 Ordinary Shares and will vest with respect to the remaining shares in two substantially equal installments on November 1, 2026 and November 1, 2027.
F4 The stock option is vested and exercisable with respect to 275 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on November 1, 2026, November 1, 2027 and November 1, 2028.
F5 The stock option will vest in substantially equal installments on January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030.

Remarks:

Exhibit 24 - Power of Attorney.